| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $256K | — | -9.2% |
| Cost of Revenue | $179K | — | -12.3% |
| Gross Profit | $77K | — | -1.3% |
| R&D Expense | $3K | — | -25.0% |
| SG&A Expense | $1.2M | — | +24.3% |
| Operating Income | -$1.1M | — | -26.3% |
| Pre-tax Income | -$765K | — | -34.7% |
| Income Tax | $0 | — | — |
| Net Income | -$765K | — | -34.7% |
| EPS (Basic) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.4M | +3.4% | +51.1% |
| Accounts Receivable | $153K | +68.1% | +10.1% |
| Inventory | $0 | -100.0% | -100.0% |
| Current Assets | $14.3M | +5.5% | +5.4% |
| Total Assets | $28.6M | -1.9% | -4.7% |
| Current Liabilities | $1.8M | +19.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$226K | — | +24.4% |
| Capital Expenditures | $315K | — | — |
| Investing Cash Flow | $466K | — | +157.4% |
| Free Cash Flow | -$541K | — | -80.9% |
| +38.3% |
| Total Liabilities | $2.2M | +9.0% | +67.9% |
| Stockholders' Equity | $26.4M | -2.7% | -8.0% |